TVMR With the Innovalve System Trial - Early Feasibility Study — TWIST-EFS

Mitral Valve Regurgitation (Degenerative or Functional) Clinical Trial

Official title:
TVMR With the Innovalve System Trial - Early Feasibility Study

Status Recruiting

Clinical Trial Summary

Study to evaluate the safety and performance of the Innovalve mitral valve replacement system

Clinical Trial Description

The study is a multi-center, First-In-Human, prospective, single arm early feasibility study to evaluate the safety and performance of the Innovalve mitral valve replacement system ;

Study Design

Related Conditions & MeSH terms

Mitral Valve Insufficiency
Mitral Valve Regurgitation (Degenerative or Functional)

Clinical Trial Details

NCT number	NCT04919980
Study type	Interventional
Source	Innovalve Bio Medical Ltd.
Contact	Director Clinical Affairs
Phone	+972-3-5308058
Email	clinicaltrials@innovalemed.com
Status	Recruiting
Phase	Phase 1
Start date	September 1, 2022
Completion date	September 1, 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05688514` - TVMR With the Innovalve System Trial - First In Human Israel	N/A
Not yet recruiting	`NCT05263375` - TVMR With the Innovalve System Trial - TWIST-BE TWIST-PILOT-BE	N/A
Recruiting	`NCT05010746` - TVMR With the Innovalve System Trial - Pilot Study in Italy	N/A
Active, not recruiting	`NCT02718001` - Edwards EVOQUE Eos MISCEND Study	N/A
Recruiting	`NCT05682066` - TVMR With the Innovalve System Trial - Pilot in Georgia	N/A